Imunon, Inc 8-K, filed Jun 14, 2022
Imunon, Inc. (IMNN)
About this 8-K
Imunon, Inc filed this 8-K on June 14, 2022.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its Charter)
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.07 | Submission of Matters to a Vote of Security Holders. |
At the Celsion Corporation’s 2022 Annual Meeting of Stockholders (the “Annual Meeting”), the following actions were taken. The proposals below are described in detail in the Company’s definitive proxy statement dated April 27, 2022 for the Annual Meeting.
Proposal 1
Mr. Michael H. Tardugno and Dr. Donald P. Braun were re-elected to the Board of Directors (the “Board”), to serve on the Board as a Class III Director until the earlier of the Company’s Annual Meeting of Stockholders in 2025 and until a successor is duly elected and qualified. The voting results were the following:
| Nominee | For | Withheld | Broker Non-Votes | |||||||||
| Michael H. Tardugno | 966,145 | 212,605 | 1,940,365 | |||||||||
| Dr. Donald P. Braun | 970,921 | 207,829 | 1,940,365 | |||||||||
In addition to Mr. Tardugno and Dr. Braun, Mr. Robert W. Hooper, Mr. Frederick J. Fritz, Dr. Augustine Chow, Dr. Stacy R. Lindborg and Ms. Christine Pellizzari continued to serve as directors after the Annual Meeting.
Proposal 2
The proposal to ratify the appointment of WithumSmith+Brown PC (“Withum”) as the independent registered public accounting firm for the fiscal year ending December 31, 2022 was approved by the stockholders. The voting results were the following:
| For | Against | Abstain | Broker Non-Votes | |||||||||
| 2,905,200 | 185,023 | 28,892 | None | |||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CELSION CORPORATION | ||
| Dated: June 14, 2022 | By: | /s/ Jeffrey W. Church |
| Jeffrey W. Church | ||
| Executive Vice President, Chief Financial Officer and Corporate Secretary | ||